Cancer screening using 18F-FDG PET/MR in asymptomatic subjects: a Retrospective Study
Conclusions: Based on the findings in this study, we suggest that FDG PET/MR might be an effective cancer screening modality in appropriate combination with other screening modalities. Table 1. Age distribution of subject and cancer detection rate in each age groupAgeNumber of subjects and percentage (%)Number with cancer and detection rate (%)20-2953 (1.90)1(1.49)30-39348(12.46)9(13.43)40-49996(35.65)15(22.39)50-59957(34.25)28(41.79)60-69361(12.92)11(16.42)70-7966(2.36)2(2.99)80 and above13(0.47)1(1.49)total2974 (100)67Table 2. 5 of 12 False positive cases detected by PET/MRNO.AgeSexorganHistological diagnosisMethods of confirmation176FColonadenomatous polypSurgery+ histology244FBreastfibroadenomaSurgery+ histology352FThyroidthyroid adenomaSurgery+ histology431MThyroidthyroid adenomaSurgery+ histology550MThyroidthyroid adenomaSurgery+ histology
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Peng, L., Lin, M., Chu, T.-C., Sun, M., Gao, X. Tags: Other Solid Tumors/ Hematologic Malignancies (Clinical) II Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carbohydrates | Carcinoma | Cervical Cancer | Colon Cancer | Colorectal Cancer | Gastric (Stomach) Cancer | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Lung Cancer | Nasopharyngeal Cancer | Nuclear Medicine | Pancreas | Pancreatic Cancer | Study | Thyroid | Thyroid Cancer | Ultrasound | Urology & Nephrology